Projects

Mgr. Aneta Ševčíková, PhD.

National

Current
  • Study of Gut Microbiome Modulation by Butyrate Administration in Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation or CAR-T Cell Therapy.
    Program: VEGA
    Duration: 1. 1. 2026 – 31. 12. 2029
  • Identification of new immune related therapeutic targets in treatment refractory testicular germ cell tumors
    Program: SRDA
    Duration: 1. 9. 2025 – 30. 6. 2029
  • Impact of the gut microbiome on the treatment and prognosis of patients with testicular germ cell tumors.
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • The emerging role of the microbiome in hematologic cancer patients receiving high-dose chemotherapy with hematopoietic stem cell transplantation.
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
Employees